HeartFlow
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, HeartFlow sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
HeartFlow: 8 sponsored US clinical trials, 2 recruiting.
HeartFlow sponsors 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Coronary Artery Disease (CAD), with 2 trials.
Upper-quartile sponsor footprint
HeartFlow sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
NCT07479433
Using CTA Measures to Define Cardiac Risk In NFL Alumni
NCT06831409
AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management
NCT06376851
Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department
NCT05325112
The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
NCT05138289
The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization
NCT03702244
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
NCT01943903
Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography
NCT01233518
Therapeutic Areas
What is open in the HeartFlow pipeline
2 recruiting of 8 indexed (25% open); 4 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Coronary Artery Disease (CAD) (2 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
HeartFlow: open-pipeline peers nationwide
Peers matched on 8 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
HeartFlow sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 25% open enrollment (± trial volume)
- Abdul Latif Jameel Poverty Action Lab · 25% recruiting · 4 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
- Advocate Hospital System · 25% recruiting · 4 trials
Related
What to do with this HeartFlow page
8 registered trials is a research-attention snapshot, not an endorsement of HeartFlow or any single study.
- 2 of HeartFlow's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease (CAD) is the condition HeartFlow studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease (CAD) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
HeartFlow pipeline card: 8 registered trials from official public datasets.Report a data error.